UFP Technologies, Inc. — Form 10-Q Summary
Reporting period: Quarter and nine months ended September 30, 2013. The interim financial statements are unaudited. UFP Technologies designs and manufactures products using foams, plastics, composites, and natural-fiber materials, serving packaging, medical, aerospace, defense, and automotive markets.
Financial performance
| Metric | Q3 2013 | Q3 2012 | Nine months 2013 | Nine months 2012 |
|---|---|---|---|---|
| Net sales | $34.7 million | $32.0 million | $104.2 million | $97.6 million |
| Gross profit / margin | $10.2 million / 29.3% | $9.2 million / 28.9% | $29.8 million / 28.6% | $28.1 million / 28.8% |
| Operating income | $4.5 million | $4.1 million | $12.1 million | $12.1 million |
| Net income | $2.9 million | $2.6 million | $7.9 million | $7.7 million |
| Diluted EPS | $0.41 | $0.37 | $1.11 | $1.09 |
| Net cash from operations | — | — | $11.5 million | $10.8 million |
Q3 sales rose 8.6% and net income rose 11.2% year over year. For the first nine months, sales increased 6.8% and net income increased 2.7%, while operating income was essentially unchanged. Reported sales include PAC, acquired at the end of 2012; excluding PAC, sales increased about 0.7% in Q3 but declined 1.3% year to date. The filing attributes Q3 margin improvement to favorable business mix; the year-to-date gross margin eased slightly.
Cash, debt, and liquidity
At September 30, 2013, cash and cash equivalents were $38.2 million, total assets $104.3 million, and working capital approximately $57.0 million. Total debt on the balance sheet was approximately $9.3 million, including $1.6 million current and $7.7 million long-term. Cash increased $4.8 million from year-end 2012. Nine-month investing cash outflow was $5.6 million, primarily capital spending; financing cash outflow was $1.2 million.
The company reported no outstanding borrowings under its $17 million revolving facility and approximately $16.9 million of availability, subject to collateral levels. That facility was due to mature November 30, 2013. Management said it was in the final stages of arranging a new $40 million unsecured facility, but could not assure completion on favorable terms or on time. The company was in compliance with its fixed-charge coverage covenant at quarter-end and expected existing resources and financing sources to meet cash needs for the next 12 months.
Drivers, outlook, and risks
- Medical-market sales were a significant growth driver, including PAC contributions. PAC contributed $2.5 million of Q3 sales and $7.9 million for the nine months.
- Defense-spending cuts weakened aerospace and defense sales. Excluding PAC, Component Products sales declined about 5.7% year to date, primarily due to military-market weakness. Automotive sales also fell, partly reflecting customer plant shutdowns early in the year.
- Engineered Packaging sales and operating income improved, supported by molded-fiber demand, added capacity, and efficiency gains. Component Products sales grew with PAC, but segment operating income declined.
- SG&A rose 10.2% year to date, primarily due to PAC. Management also cited approximately $150,000 of one-time costs associated with PAC integration and absorbing the El Paso beauty business.
- The nine-month effective tax rate was 33.9%, including a $135,000 first-quarter tax benefit from the retroactive 2012 research and development credit; excluding that item, the rate was 35.0%.
- Management planned further capacity and efficiency investment and said it may pursue complementary acquisitions. It identified risks involving economic and market conditions, customer order changes, competition, acquisition integration, new equipment and capacity utilization, and plant consolidation. No specific financial guidance was provided; management cautioned interim results are not necessarily indicative of full-year results.
Important facts for investors to verify
- Whether the replacement credit facility closed, its final terms, and any implications of the November 30, 2013 maturity of the existing revolver.
- Whether organic sales and Component Products profitability recover as defense-related weakness and automotive declines persist.
- Whether PAC integration and the Ventura plant closure/consolidation deliver the expected benefits and whether related costs remain limited.
- Whether molded-fiber investments generate expected utilization, efficiency, and returns while capital spending continues.
- How results compare with management’s cash-flow expectations, given working-capital movements and scheduled debt and lease obligations.